| 0 |
ADMINISTRATION SITE DISCOLOURATION |
2 |
0.0160 |
| 1 |
LOCAL REACTION |
9 |
0.0121 |
| 2 |
SKIN TEST NEGATIVE |
1 |
0.0099 |
| 3 |
ADMINISTRATION SITE SWELLING |
1 |
0.0031 |
| 4 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 5 |
INJECTION SITE HYPOAESTHESIA |
3 |
0.0021 |
| 6 |
MANUFACTURING PRODUCT SHIPPING ISSUE |
1 |
0.0018 |
| 7 |
ADMINISTRATION SITE PAIN |
2 |
0.0017 |
| 8 |
NASAL PRURITUS |
2 |
0.0016 |
| 9 |
LIP ERYTHEMA |
1 |
0.0013 |
| 10 |
THROAT CLEARING |
4 |
0.0011 |
| 11 |
ANAPHYLACTIC REACTION |
49 |
0.0009 |
| 12 |
ORAL PRURITUS |
2 |
0.0009 |
| 13 |
WRONG DOSE |
2 |
0.0008 |
| 14 |
PRODUCT PACKAGING CONFUSION |
2 |
0.0008 |
| 15 |
ENDOTRACHEAL INTUBATION |
2 |
0.0007 |
| 16 |
PRODUCT MONITORING ERROR |
1 |
0.0007 |
| 17 |
INJECTION SITE PARAESTHESIA |
1 |
0.0007 |
| 18 |
THROAT IRRITATION |
27 |
0.0006 |
| 19 |
THROAT TIGHTNESS |
13 |
0.0005 |
| 20 |
EYE OEDEMA |
1 |
0.0004 |
| 21 |
LIP BLISTER |
1 |
0.0004 |
| 22 |
SINUS CONGESTION |
4 |
0.0003 |
| 23 |
EAR PRURITUS |
1 |
0.0003 |
| 24 |
EYE PRURITUS |
9 |
0.0003 |
| 25 |
SNEEZING |
6 |
0.0003 |
| 26 |
EYELID OEDEMA |
3 |
0.0003 |
| 27 |
WHEEZING |
13 |
0.0002 |
| 28 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 29 |
EAR DISCOMFORT |
2 |
0.0002 |
| 30 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 31 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 32 |
URTICARIA |
29 |
0.0002 |
| 33 |
INJECTION SITE REACTION |
11 |
0.0002 |
| 34 |
RHINORRHOEA |
10 |
0.0002 |
| 35 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 36 |
SWELLING FACE |
10 |
0.0002 |
| 37 |
DROOLING |
1 |
0.0001 |
| 38 |
CHEST DISCOMFORT |
14 |
0.0001 |
| 39 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 40 |
FOOD ALLERGY |
1 |
0.0001 |
| 41 |
PRESYNCOPE |
3 |
0.0001 |
| 42 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 43 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 44 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 45 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 46 |
DRUG ERUPTION |
2 |
0.0001 |
| 47 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 48 |
EYE SWELLING |
4 |
0.0001 |
| 49 |
FLUSHING |
10 |
0.0001 |
| 50 |
INJECTION SITE URTICARIA |
2 |
0.0001 |
| 51 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 52 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 53 |
ADVERSE REACTION |
1 |
0.0001 |
| 54 |
COUGH |
21 |
0.0001 |
| 55 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 56 |
BRAIN FOG |
1 |
0.0001 |
| 57 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 58 |
LIP SWELLING |
2 |
0.0001 |
| 59 |
PRURITUS |
23 |
0.0001 |
| 60 |
INJECTION SITE PRURITUS |
4 |
0.0001 |
| 61 |
RASH MACULAR |
2 |
0.0001 |
| 62 |
FEELING JITTERY |
1 |
0.0001 |
| 63 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 64 |
INJECTION SITE WARMTH |
1 |
0.0000 |
| 65 |
DYSPNOEA |
26 |
0.0000 |
| 66 |
GLOSSODYNIA |
1 |
0.0000 |
| 67 |
ERYTHEMA |
9 |
0.0000 |
| 68 |
HYPERSENSITIVITY |
8 |
0.0000 |
| 69 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 70 |
INJECTION SITE ERYTHEMA |
5 |
0.0000 |
| 71 |
PALLOR |
1 |
0.0000 |
| 72 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 73 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 74 |
NASAL CONGESTION |
2 |
0.0000 |
| 75 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 76 |
HEART RATE INCREASED |
3 |
0.0000 |
| 77 |
HYPOXIA |
1 |
0.0000 |
| 78 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 79 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 80 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 81 |
DIZZINESS |
13 |
0.0000 |
| 82 |
DISORIENTATION |
1 |
0.0000 |
| 83 |
TINNITUS |
1 |
0.0000 |
| 84 |
SWELLING |
2 |
0.0000 |
| 85 |
DYSPHAGIA |
2 |
0.0000 |
| 86 |
SYNCOPE |
2 |
0.0000 |
| 87 |
NERVOUSNESS |
1 |
0.0000 |
| 88 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 89 |
RASH PRURITIC |
1 |
0.0000 |
| 90 |
LETHARGY |
1 |
0.0000 |
| 91 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 92 |
INJECTION SITE PAIN |
5 |
0.0000 |
| 93 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 94 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 95 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 96 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 97 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 98 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 99 |
CHEST PAIN |
2 |
0.0000 |
| 100 |
RASH |
4 |
0.0000 |
| 101 |
ASTHMA |
1 |
0.0000 |
| 102 |
SEIZURE |
1 |
0.0000 |
| 103 |
HYPERHIDROSIS |
1 |
0.0000 |
| 104 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 105 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 106 |
VOMITING |
3 |
0.0000 |
| 107 |
OFF LABEL USE |
5 |
0.0000 |
| 108 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 109 |
ASTHENIA |
2 |
0.0000 |
| 110 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 111 |
ALOPECIA |
1 |
0.0000 |
| 112 |
HYPOTENSION |
1 |
0.0000 |
| 113 |
SOMNOLENCE |
1 |
0.0000 |
| 114 |
ARTHRALGIA |
2 |
0.0000 |
| 115 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 116 |
FATIGUE |
3 |
0.0000 |
| 117 |
NAUSEA |
3 |
0.0000 |
| 118 |
WEIGHT DECREASED |
1 |
0.0000 |
| 119 |
ANXIETY |
1 |
0.0000 |
| 120 |
HEADACHE |
2 |
0.0000 |
| 121 |
DIARRHOEA |
1 |
0.0000 |
| 122 |
DRUG INEFFECTIVE |
1 |
0.0000 |